NNNN Margin bathi reged Anbio Corp

Simbol resmi perusahaan Anbio Tech (NNNN)

Anbio Biotechnology is actively developing R&D by creating compact analyzers for rapid diagnostics. Gross margin dynamics provide an objective assessment of the business's manufacturing successes, while 87.10 indicates the current level. High physician confidence in the accuracy of Anbio test systems combines with growth potential driven by expansion and the trend toward preventive medicine.

NNNN (anbio.com) riwayat Margin reged saka 20.02.2025 nganti 20.11.2026

Rincian analitis lan laporan data perusahaan Anbio Biotechnology Ltd (NNNN)

- kuotasi saiki lan rata-rata prakiraan nilai:
Ringkesan analisis perusahaan:Anbio - NNNN
Produk seri Anbio

By leveraging academic alliances to develop its pipeline, Anbio Biotechnology (NNNN) minimizes capital expenditures through joint research. The gross margin trajectory reflects the portion of revenue remaining after direct costs, allowing investors to assess production efficiency and the business's pricing power relative to industry standards, where steady growth of this indicator signals the optimization of operating expenses.